001     836751
005     20210129231056.0
024 7 _ |a 10.1016/j.jconrel.2017.07.040
|2 doi
024 7 _ |a 0168-3659
|2 ISSN
024 7 _ |a 1873-4995
|2 ISSN
024 7 _ |a 2128/16032
|2 Handle
024 7 _ |a pmid:28764995
|2 pmid
024 7 _ |a WOS:000411201100019
|2 WOS
024 7 _ |a altmetric:23453022
|2 altmetric
037 _ _ |a FZJ-2017-05804
082 _ _ |a 540
100 1 _ |a Sheng, Yingjie
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer
260 _ _ |a New York, NY [u.a.]
|c 2017
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1522164929_11572
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Magnetically responsive microbubbles (MagMBs), consisting of an oxygen gas core and a phospholipid coating functionalised with Rose Bengal (RB) and/or 5-fluorouracil (5-FU), were assessed as a delivery vehicle for the targeted treatment of pancreatic cancer using combined antimetabolite and sonodynamic therapy (SDT). MagMBs delivering the combined 5-FU/SDT treatment produced a reduction in cell viability of over 50% when tested against a panel of four pancreatic cancer cell lines in vitro. Intravenous administration of the MagMBs to mice bearing orthotopic human xenograft BxPC-3 tumours yielded a 48.3% reduction in tumour volume relative to an untreated control group (p < 0.05) when the tumour was exposed to both external magnetic and ultrasound fields during administration of the MagMBs. In contrast, application of an external ultrasound field alone resulted in a 27% reduction in tumour volume. In addition, activated caspase and BAX protein levels were both observed to be significantly elevated in tumours harvested from animals treated with the MagMBs in the presence of magnetic and ultrasonic fields when compared to expression of those proteins in tumours from either the control or ultrasound field only groups (p < 0.05). These results suggest MagMBs have considerable potential as a platform to enable the targeted delivery of combined sonodynamic/antimetabolite therapy in pancreatic cancer.
536 _ _ |0 G:(DE-HGF)POF3-6G15
|f POF III
|x 0
|c POF3-6G15
|a 6G15 - FRM II / MLZ (POF3-6G15)
536 _ _ |a 6G4 - Jülich Centre for Neutron Research (JCNS) (POF3-623)
|0 G:(DE-HGF)POF3-6G4
|c POF3-623
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef
650 2 7 |a Medicine
|0 V:(DE-MLZ)SciArea-190
|2 V:(DE-HGF)
|x 0
650 2 7 |a Soft Condensed Matter
|0 V:(DE-MLZ)SciArea-210
|2 V:(DE-HGF)
|x 1
650 2 7 |a Magnetism
|0 V:(DE-MLZ)SciArea-170
|2 V:(DE-HGF)
|x 2
650 1 7 |a Health and Life
|0 V:(DE-MLZ)GC-130-2016
|2 V:(DE-HGF)
|x 0
693 _ _ |0 EXP:(DE-MLZ)NOSPEC-20140101
|5 EXP:(DE-MLZ)NOSPEC-20140101
|e No specific instrument
|x 0
700 1 _ |a Beguin, Estelle
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Nesbitt, Heather
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Kamila, Sukanta
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Owen, Joshua
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Barnsley, Lester
|0 P:(DE-Juel1)172014
|b 5
|u fzj
700 1 _ |a Callan, Bridgeen
|0 P:(DE-HGF)0
|b 6
700 1 _ |a O'Kane, Christopher
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Nomikou, Nikolitsa
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Hamoudi, Rifat
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Taylor, Mark A.
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Love, Mark
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Kelly, Paul
|0 P:(DE-HGF)0
|b 12
700 1 _ |a O'Rourke, Declan
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Stride, Eleanor
|0 P:(DE-HGF)0
|b 14
|e Corresponding author
700 1 _ |a McHale, Anthony P.
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Callan, John F.
|0 P:(DE-HGF)0
|b 16
|e Corresponding author
773 _ _ |a 10.1016/j.jconrel.2017.07.040
|g Vol. 262, p. 192 - 200
|0 PERI:(DE-600)1482453-x
|p 192 - 200
|t Journal of controlled release
|v 262
|y 2017
|x 0168-3659
856 4 _ |u https://juser.fz-juelich.de/record/836751/files/1-s2.0-S0168365917307605-main.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/836751/files/1-s2.0-S0168365917307605-main.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/836751/files/1-s2.0-S0168365917307605-main.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/836751/files/1-s2.0-S0168365917307605-main.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/836751/files/1-s2.0-S0168365917307605-main.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/836751/files/1-s2.0-S0168365917307605-main.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:836751
|p openaire
|p open_access
|p driver
|p VDB:MLZ
|p VDB
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)172014
913 1 _ |a DE-HGF
|9 G:(DE-HGF)POF3-6G15
|x 0
|4 G:(DE-HGF)POF
|v FRM II / MLZ
|1 G:(DE-HGF)POF3-6G0
|0 G:(DE-HGF)POF3-6G15
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-600
|b Forschungsbereich Materie
|l Großgeräte: Materie
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Von Materie zu Materialien und Leben
|1 G:(DE-HGF)POF3-620
|0 G:(DE-HGF)POF3-623
|2 G:(DE-HGF)POF3-600
|v Facility topic: Neutrons for Research on Condensed Matter
|9 G:(DE-HGF)POF3-6G4
|x 1
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CONTROL RELEASE : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J CONTROL RELEASE : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)JCNS-FRM-II-20110218
|k JCNS (München) ; Jülich Centre for Neutron Science JCNS (München) ; JCNS-FRM-II
|l JCNS-FRM-II
|x 0
920 1 _ |0 I:(DE-Juel1)JCNS-1-20110106
|k Neutronenstreuung ; JCNS-1
|l Neutronenstreuung
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)JCNS-FRM-II-20110218
980 _ _ |a I:(DE-Juel1)JCNS-1-20110106
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21